S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

NYSE:BDX - Becton Dickinson and Stock Price, Forecast & News

$257.35
+3.89 (+1.53 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$252.38
Now: $257.35
$258.79
50-Day Range
$246.91
MA: $270.32
$285.99
52-Week Range
$221.47
Now: $257.35
$286.72
Volume1.87 million shs
Average Volume1.81 million shs
Market Capitalization$69.79 billion
P/E Ratio94.61
Dividend Yield1.25%
Beta1.08
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07588710
Phone201-847-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.29 billion
Cash Flow$20.87 per share
Book Value$78.18 per share

Profitability

Net Income$1.23 billion

Miscellaneous

Employees70,093
Market Cap$69.79 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.


Becton Dickinson and (NYSE:BDX) Frequently Asked Questions

What is Becton Dickinson and's stock symbol?

Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and?

Becton Dickinson and announced a quarterly dividend on Monday, January 27th. Shareholders of record on Tuesday, March 10th will be given a dividend of $0.79 per share on Tuesday, March 31st. This represents a $3.16 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend is Monday, March 9th. View Becton Dickinson and's Dividend History.

How were Becton Dickinson and's earnings last quarter?

Becton Dickinson and Co (NYSE:BDX) released its earnings results on Thursday, February, 6th. The medical instruments supplier reported $2.65 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.63 by $0.02. The medical instruments supplier earned $4.23 billion during the quarter, compared to analysts' expectations of $4.19 billion. Becton Dickinson and had a net margin of 4.96% and a return on equity of 15.50%. The firm's revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the business earned $2.70 earnings per share. View Becton Dickinson and's Earnings History.

When is Becton Dickinson and's next earnings date?

Becton Dickinson and is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for Becton Dickinson and.

What guidance has Becton Dickinson and issued on next quarter's earnings?

Becton Dickinson and issued an update on its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of $11.90-$12.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.56.

What price target have analysts set for BDX?

13 equities research analysts have issued 12-month target prices for Becton Dickinson and's stock. Their forecasts range from $250.00 to $300.00. On average, they anticipate Becton Dickinson and's share price to reach $279.38 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price. View Analyst Price Targets for Becton Dickinson and.

What is the consensus analysts' recommendation for Becton Dickinson and?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Becton Dickinson and in the last year. There are currently 6 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Becton Dickinson and.

Has Becton Dickinson and been receiving favorable news coverage?

Media stories about BDX stock have trended somewhat negative recently, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Becton Dickinson and earned a daily sentiment score of -1.7 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Becton Dickinson and.

Who are some of Becton Dickinson and's key competitors?

What other stocks do shareholders of Becton Dickinson and own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Becton Dickinson and investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Exxon Mobil (XOM), NVIDIA (NVDA), Visa (V), Abbott Laboratories (ABT), AbbVie (ABBV), Home Depot (HD), AT&T (T) and Procter & Gamble (PG).

Who are Becton Dickinson and's key executives?

Becton Dickinson and's management team includes the folowing people:
  • Mr. Vincent A. Forlenza, Chairman & CEO (Age 66)
  • Mr. Thomas E. Polen Jr., Pres & COO (Age 46)
  • Mr. Christopher R. Reidy, Exec. VP, CFO & Chief Admin. Officer (Age 62)
  • Mr. Samrat S. Khichi, Exec. VP & Gen. Counsel (Age 52)
  • Mr. Patrick K. Kaltenbach, Exec. VP & Pres of the Life Sciences Segment (Age 56)

Who are Becton Dickinson and's major shareholders?

Becton Dickinson and's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Wealth Quarterback LLC (27.99%), FMR LLC (4.98%), State Street Corp (4.23%), Geode Capital Management LLC (1.36%), Franklin Resources Inc. (1.33%) and Fiera Capital Corp (1.28%). Company insiders that own Becton Dickinson and stock include Alexandre Conroy, Betty D Larson, Catherine M Burzik, Charles R Bodner, Claire Fraser, David F Melcher, James C Lim, James W Borzi, John E Gallagher, Nabil Shabshab, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas E Polen Jr, Thomas J Spoerel, Timothy M Ring and Vincent A Forlenza. View Institutional Ownership Trends for Becton Dickinson and.

Which institutional investors are selling Becton Dickinson and stock?

BDX stock was sold by a variety of institutional investors in the last quarter, including GQG Partners LLC, Janus Henderson Group PLC, AXA, Montag & Caldwell LLC, Russell Investments Group Ltd., Bank of Montreal Can, Swiss National Bank and TD Asset Management Inc.. Company insiders that have sold Becton Dickinson and company stock in the last year include Alexandre Conroy, Betty D Larson, Charles R Bodner, Claire Fraser, James C Lim, Patrick Kaltenbach, Ribo Alberto Mas, Roland Goette, Samrat S Khichi, Simon D Campion, Thomas J Spoerel and Vincent A Forlenza. View Insider Buying and Selling for Becton Dickinson and.

Which institutional investors are buying Becton Dickinson and stock?

BDX stock was bought by a variety of institutional investors in the last quarter, including Wealth Quarterback LLC, Massachusetts Financial Services Co. MA, Prudential Financial Inc., M&G Investment Management Ltd., FMR LLC, Loomis Sayles & Co. L P, Marshall Wace North America L.P. and Stifel Financial Corp. Company insiders that have bought Becton Dickinson and stock in the last two years include Catherine M Burzik and David F Melcher. View Insider Buying and Selling for Becton Dickinson and.

How do I buy shares of Becton Dickinson and?

Shares of BDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Becton Dickinson and's stock price today?

One share of BDX stock can currently be purchased for approximately $257.35.

How big of a company is Becton Dickinson and?

Becton Dickinson and has a market capitalization of $69.79 billion and generates $17.29 billion in revenue each year. The medical instruments supplier earns $1.23 billion in net income (profit) each year or $11.68 on an earnings per share basis. Becton Dickinson and employs 70,093 workers across the globe.View Additional Information About Becton Dickinson and.

What is Becton Dickinson and's official website?

The official website for Becton Dickinson and is http://www.bd.com/.

How can I contact Becton Dickinson and?

Becton Dickinson and's mailing address is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. The medical instruments supplier can be reached via phone at 201-847-6800.


MarketBeat Community Rating for Becton Dickinson and (NYSE BDX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  516 (Vote Outperform)
Underperform Votes:  594 (Vote Underperform)
Total Votes:  1,110
MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and and other stocks. Vote "Outperform" if you believe BDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel